References
- 1. Esposito S, Tagliabue C, Picciolli I, et al. Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia. Respiratory Medicine. 2011;105(12):1939-194510.1016/j.rmed.2011.09.003
- 2. de Jong E, van Oers JA, Beishuizen A, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomized, controlled, open-label trial. The Lancet Infectious Diseases. 2016;16:819-27.10.1016/S1473-3099(16)00053-0
- 3. Iordachescu F. Tratat de Pediatrie. Editura ALL; 2019.
- 4. Gomez B, Bressan S, Mintegi S, et al. Diagnostic value of procalcitonin in well-appearing young febrile infants. Pediatrics. 2012;130(5).10.1542/peds.2011-3575
- 5. Schuetz P, Mueller B. Procalcitonin in critically ill patients: time to change guidelines and antibiotic use in practice. Lancet Infect Dis. 2016;16:758-60.10.1016/S1473-3099(16)00064-5
- 6. Deis JN, Creech CB, Estrada CM, et al. Pocalcitonin as a marker of severe bacterial infection in children in the emergency department. Pediatr Emerg Care. 2010;26(1):51-60.10.1097/PEC.0b013e3181c399df20065834
- 7. Gilbert D. Serum procalcitonin levels. It is all about confidence. Arch Intern Med. 2012;172:722-23.